Johnson & Johnson reported an 8.6 percent fall in quarterly profit as the impact of a strong dollar on overseas revenue offset growing sales of its mainstay older drugs.

The company's net profit fell to $4.32 billion, or $1.53 per share, in the first quarter, from $4.73 billion, or $1.64 per share, a year earlier.

Revenue fell 4.1 percent to $17.37 billion.